Drug:
Reaction: DEVICE MALFUNCTION
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26852839 |
US |
61 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, HYDROCHLOROTHIAZIDE, |
||||
| 602 | 26852908 |
US |
74 | |
Device malfunction, Drug dose omission by device, Device issue, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 603 | 26852912 |
US |
68 | |
Exposure via skin contact, Accidental exposure to product, Device malfunction, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 604 | 26852922 |
US |
73 | |
Device malfunction, Incorrect dose administered by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 605 | 26852933 |
US |
43 | |
Device malfunction, Incorrect dose administered by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 606 | 26852938 |
US |
30 | |
Device malfunction, Needle issue, Drug dose omission by device, Suspected off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 607 | 26852962 |
US |
54 | |
Bronchitis, Urinary tract infection, Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 608 | 26852979 |
US |
74 | 2 |
Device malfunction, Accidental exposure to product, Product dose omission issue, Injection site pain, Slow speech, |
||||
GUSELKUMAB, |
||||
| 609 | 26852981 |
US |
26 | |
Device malfunction, Product dose omission issue, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 610 | 26853007 |
US |
64 | |
Incorrect dose administered, Device malfunction, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 611 | 26853616 |
US |
53 | 2 |
Contusion, Device malfunction, |
||||
| 612 | 26853704 |
US |
2 | |
Blood glucose increased, Device malfunction, |
||||
INSULIN ASPART, |
||||
| 613 | 26853783 |
US |
46 | 1 |
Device mechanical issue, No adverse event, Device malfunction, |
||||
LIRAGLUTIDE, |
||||
| 614 | 26853792 |
US |
33 | |
Injection site indentation, Device malfunction, Device leakage, |
||||
| 615 | 26853854 |
US |
2 | |
Device malfunction, No adverse event, |
||||
LIRAGLUTIDE, |
||||
| 616 | 26853887 |
US |
||
Incorrect dose administered by device, Visual impairment, Glycosylated haemoglobin decreased, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 617 | 26853890 |
US |
||
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 618 | 26853898 |
US |
70 | 1 |
Nausea, Constipation, Dyspepsia, Muscle spasms, Product dose omission issue, Diarrhoea, Device malfunction, Device leakage, |
||||
EVOLOCUMAB, |
||||
| 619 | 26854150 |
US |
60 | 2 |
Device malfunction, No adverse event, Drug dose omission by device, Device defective, Incorrect dose administered by device, Device delivery system issue, |
||||
LIRAGLUTIDE, LISINOPRIL, LOVASTATIN, EMPAGLIFLOZIN, AMLODIPINE, |
||||
| 620 | 26854196 |
US |
34 | 2 |
Off label use, Intercepted product administration error, Wrong technique in product usage process, Device malfunction, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 621 | 26854234 |
US |
||
Visual impairment, Device malfunction, |
||||
| 622 | 26854340 |
BR |
2 | |
Pulmonary fibrosis, Pneumonia, Pneumonia, Lung disorder, Lung disorder, Chronic obstructive pulmonary disease, Fatigue, Off label use, Product ineffective for unapproved use, Device malfunction, Product ineffective for unapproved use, Device malfunction, Product ineffective for unapproved use, Device malfunction, Product ineffective for unapproved use, Device malfunction, Product ineffective for unapproved use, Device malfunction, |
||||
BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, DESVENLAFAXINE SUCCINATE, PREGABALIN, ZOLPIDEM TARTRATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ERGOCALCIFEROL, MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, |
||||
| 623 | 26854369 |
US |
66 | |
Blood glucose fluctuation, Device malfunction, |
||||
ORAL SEMAGLUTIDE, |
||||
| 624 | 26854493 |
US |
43 | 2 |
Device delivery system issue, No adverse event, Device malfunction, Device mechanical issue, Drug dose omission by device, |
||||
LIRAGLUTIDE, |
||||
| 625 | 26854551 |
US |
||
Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 626 | 26854728 |
US |
50 | 1 |
Wrong technique in device usage process, Product prescribing issue, Device delivery system issue, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 627 | 26854783 |
US |
42 | |
Incorrect dose administered, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 628 | 26854796 |
US |
63 | 2 |
Rhinovirus infection, Wrong technique in device usage process, Device malfunction, |
||||
OMALIZUMAB, |
||||
| 629 | 26855346 |
US |
75 | |
Incorrect dose administered by device, Device malfunction, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 630 | 26855363 |
US |
47 | |
Device malfunction, Device delivery system issue, Exposure via skin contact, Accidental exposure to product, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, DULOXETINE HYDROCHLORIDE, BACLOFEN, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, SULFASALAZINE, |
||||
| 631 | 26855400 |
US |
72 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, Drug dose omission by device, Suspected off label use, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, COLESTIPOL HYDROCHLORIDE, |
||||
| 632 | 26855410 |
US |
||
Device malfunction, Wrong technique in product usage process, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 633 | 26855440 |
US |
65 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 634 | 26855962 |
US |
||
Product dose omission issue, Device malfunction, |
||||
BIMEKIZUMAB, |
||||
| 635 | 26856066 |
US |
79 | 2 |
Device malfunction, Product storage issue, |
||||
ABATACEPT, AMLODIPINE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, BACLOFEN, DAPAGLIFLOZIN, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, POLYETHYLENE GLYCOL 3350, SPIRONOLACTONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ERGOCALCIFEROL, WARFARIN, LEVALBUTEROL TARTRATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 636 | 26856192 |
US |
2 | |
Inappropriate schedule of product administration, Device malfunction, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 637 | 26856396 |
US |
30 | 1 |
Injection site discomfort, Product use in unapproved indication, Device malfunction, |
||||
TRALOKINUMAB-LDRM, |
||||
| 638 | 26857091 |
US |
70 | |
Incorrect dose administered, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, TIRZEPATIDE, |
||||
| 639 | 26857098 |
US |
49 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 640 | 26857158 |
US |
42 | 2 |
Needle issue, Device malfunction, Device leakage, Accidental exposure to product, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 641 | 26857265 |
US |
1 | |
Furuncle, Needle issue, Device leakage, Device malfunction, |
||||
SECUKINUMAB, LORAZEPAM, |
||||
| 642 | 26847197 |
US |
37 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 643 | 26847221 |
US |
66 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 644 | 26847267 |
BR |
2 | |
Ill-defined disorder, Amyotrophic lateral sclerosis, Wrong technique in device usage process, Wrong technique in device usage process, Device malfunction, Device physical property issue, |
||||
BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRROLATE, RILUZOLE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 645 | 26847353 |
US |
46 | 1 |
Skin injury, Device malfunction, Product quality issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 646 | 26847815 |
US |
44 | 1 |
Intentional overdose, Self-medication, Device deployment issue, Device malfunction, Product dose omission issue, Wrong technique in product usage process, |
||||
GUSELKUMAB, |
||||
| 647 | 26847889 |
US |
2 | |
Incorrect dose administered by product, Device malfunction, |
||||
INSULIN DEGLUDEC, |
||||
| 648 | 26848116 |
US |
78 | 1 |
Weight increased, Device failure, Product dose omission issue, Device malfunction, Device issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 649 | 26848276 |
US |
||
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 650 | 26848334 |
US |
||
Device malfunction, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 651 | 26848369 |
US |
42 | |
Dermatitis atopic, Device malfunction, Product dose omission issue, Off label use, Intentional underdose, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 652 | 26848812 |
US |
76 | 2 |
Rash, Pruritus, Device malfunction, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 653 | 26849212 |
US |
2 | |
Incorrect dose administered, Device malfunction, |
||||
BELIMUMAB, |
||||
| 654 | 26849296 |
US |
60 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 655 | 26849597 |
US |
||
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 656 | 26849842 |
US |
2 | |
Device malfunction, Injection site pain, Device leakage, |
||||
SECUKINUMAB, |
||||
| 657 | 26849975 |
US |
71 | 2 |
Injection site haemorrhage, Device malfunction, |
||||
TRALOKINUMAB-LDRM, |
||||
| 658 | 26850000 |
CN |
||
Wrong technique in product usage process performed in error, Product delivery mechanism issue, Device malfunction, |
||||
| 659 | 26850012 |
US |
76 | 1 |
Device malfunction, Device delivery system issue, Product quality issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 660 | 26850016 |
US |
||
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 661 | 26850199 |
US |
1 | |
Device malfunction, Wrong technique in device usage process, Product leakage, |
||||
GUSELKUMAB, |
||||
| 662 | 26850406 |
US |
||
Device malfunction, Product leakage, Product dose omission issue, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 663 | 26851395 |
US |
||
Device malfunction, |
||||
GUSELKUMAB, |
||||
| 664 | 26851924 |
US |
2 | |
Injection site indentation, Device malfunction, Drug dose omission by device, |
||||
| 665 | 26851929 |
US |
69 | 2 |
Drug dose omission by device, Device malfunction, Device leakage, |
||||
| 666 | 26856679 |
1 | ||
Vascular device occlusion, Device malfunction, |
||||
MACITENTAN, EPOPROSTENOL, |
||||
| 667 | 26856830 |
1 | ||
Complication associated with device, Device malfunction, Device occlusion, |
||||
TADALAFIL, EPOPROSTENOL, |
||||
| 668 | 26845973 |
US |
||
Device malfunction, No adverse event, |
||||
ENOXAPARIN SODIUM, |
||||
| 669 | 26844950 |
US |
78 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 670 | 26844954 |
US |
75 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 671 | 26844967 |
US |
76 | |
Device malfunction, Off label use, Inappropriate schedule of product administration, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 672 | 26844970 |
US |
||
Product leakage, Device malfunction, Suspected off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 673 | 26845021 |
US |
77 | |
Device malfunction, Drug dose omission by device, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 674 | 26845033 |
US |
39 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 675 | 26845131 |
US |
68 | |
Device malfunction, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, ORAL SEMAGLUTIDE, |
||||
| 676 | 26845162 |
US |
||
No adverse event, Device malfunction, Device malfunction, No adverse event, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 677 | 26845364 |
US |
||
Incorrect dose administered by device, Device malfunction, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 678 | 26845594 |
US |
2 | |
No adverse event, Device malfunction, No adverse event, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, |
||||
| 679 | 26845678 |
US |
||
Device malfunction, |
||||
NITRIC OXIDE, NITRIC OXIDE, |
||||
| 680 | 26839732 |
US |
43 | |
Device malfunction, Injection site pain, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 681 | 26839754 |
US |
56 | |
Device malfunction, Product dose omission issue, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 682 | 26839774 |
US |
77 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 683 | 26839785 |
US |
74 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 684 | 26839859 |
US |
36 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, Wrong technique in product usage process, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 685 | 26839881 |
US |
72 | |
Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 686 | 26839970 |
US |
69 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 687 | 26839996 |
US |
69 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 688 | 26840096 |
US |
44 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 689 | 26840114 |
CN |
39 | |
Diabetic foot, Injection site mass, Product quality issue, Device malfunction, |
||||
| 690 | 26840149 |
US |
38 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 691 | 26840228 |
US |
68 | |
Injection site bruising, Device malfunction, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 692 | 26840298 |
US |
11 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 693 | 26840323 |
US |
49 | |
Device malfunction, Accidental exposure to product, Exposure via skin contact, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 694 | 26840401 |
US |
70 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 695 | 26840431 |
US |
83 | |
Device malfunction, Drug dose omission by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 696 | 26840453 |
US |
||
Device malfunction, Exposure via skin contact, Accidental exposure to product, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 697 | 26840515 |
US |
62 | |
Device malfunction, Incorrect dose administered by device, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 698 | 26840690 |
US |
33 | |
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 699 | 26840791 |
US |
46 | 2 |
Condition aggravated, Product dose omission issue, Device malfunction, |
||||
ADALIMUMAB-RYVK, |
||||
| 700 | 26841234 |
US |
71 | 1 |
Device infusion issue, Device malfunction, Product dose omission issue, Product dose omission issue, Device infusion issue, Device malfunction, |
||||
PEGFILGRASTIM-CBQV, PEGFILGRASTIM-CBQV, PEGFILGRASTIM-CBQV, PEGFILGRASTIM-CBQV, EPINEPHRINE, ADRENALINUM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30